Showing results (21-30 of 110) with videos related to

Sort By:
Pageof 11
Expert Opinion on Drug Metabolism & Toxicology|August 4, 2017
Biological anti-TNF drugs: immunogenicity underlying treatment failure and adverse eventsMônica Simon Prado, Klaus Bendtzen, Luis Eduardo Coelho Andrade
European Journal of Immunology|September 16, 2004
High levels of neutralizing IL-6 autoantibodies in 0.1% of apparently healthy blood donorsPia Galle, Morten Svenson, Klaus Bendtzen, et al.
Journal of Interferon & Cytokine Research : the Official Journal of the International Society for Interferon and Cytokine Research|May 30, 2002
IFN-alpha antibodies in patients with age-related macular degeneration treated with recombinant human IFN-alpha2aChristian Ross, Claus Bødker Engler, Birgit Sander, et al.
Drug Discovery Today|June 1, 2011
mTOR as a multifunctional therapeutic target in HIV infectionFerdinando Nicoletti, Paolo Fagone, PierLuigi Meroni, et al.
International Immunopharmacology|December 14, 2004
Cytokines and soluble tumour necrosis factor I receptor levels during pretransplant conditioning in allogeneic stem-cell transplantationJohnny Andersen, Carsten Heilmann, Niels Jacobsen, et al.
European Journal of Pharmacology|July 18, 2018
Gasotransmitters and the immune system: Mode of action and novel therapeutic targetsPaolo Fagone, Emanuela Mazzon, Placido Bramanti, et al.
Journal of Critical Care|October 22, 2013
Melatonin suppresses markers of inflammation and oxidative damage in a human daytime endotoxemia modelMahdi Alamili, Klaus Bendtzen, Jens Lykkesfeldt, et al.
Journal of Periodontology|February 4, 2009
Aggressive periodontitis and chronic arthritis: blood mononuclear cell gene expression and plasma protein levels of cytokines and cytokine inhibitorsLars K Sørensen, Anne Havemose-Poulsen, Klaus Bendtzen, et al.
Pageof 11